Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, October 23, 2014

With Regards to Tecfidera

After the recent news of PML being found in a Tecfidera patient from Europe, a health care clinician wanted to share some information:

My recommendation as of now is that all patients starting on Tecfidera be tested for the presence of antibodies to the JC virus and , if present, be warned that PML is a possibility...especially (historically) if there has been prior treatment with Cytoxan, Imuran, Methotrexate, CellCept, or even long term high dose steroids.

 While on Tecfidera, patients should be monitored for the presence of these antibodies at least annually. 

 This is not a formal recommendation but one which is being made effective immediately to all prescribers and persons taking this particular medication.

Cherie C. Binns RN BS MSCN

Cherie Binns, RN BS MSCN, is  writing on her own accord. Stu's Views and MS News had no input into the information being shared


No comments: